pyrazolanthrone has been researched along with cystamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SY; Lee, CH; Lee, HJ; Noh, M; Park, MK; Shin, J | 1 |
| Kang, JH; Kim, SY; Lee, CH; Lee, HJ; Oh, SH; Park, MK; You, HJ | 1 |
2 other study(ies) available for pyrazolanthrone and cystamine
| Article | Year |
|---|---|
Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
Topics: Anthracenes; Cell Line, Tumor; Cell Movement; Cystamine; Cytoskeleton; Gene Expression Regulation, Neoplastic; Gene Silencing; GTP-Binding Proteins; Humans; Immunoprecipitation; JNK Mitogen-Activated Protein Kinases; Keratin-8; MAP Kinase Signaling System; Pancreatic Neoplasms; Phosphorylation; Phosphorylcholine; Protein Glutamine gamma Glutamyltransferase 2; Protein Kinase Inhibitors; RNA, Small Interfering; Serine; Sphingosine; Transglutaminases | 2011 |
Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Topics: Animals; Anthracenes; Blotting, Western; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Cystamine; Enzyme Activation; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; GTP-Binding Proteins; HEK293 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mice; Mice, SCID; Protein Glutamine gamma Glutamyltransferase 2; Protein Phosphatase 2; RNA Interference; Transforming Growth Factor beta1; Transglutaminases; Transplantation, Heterologous | 2013 |